CLINICAL_TRIALS
trial_result
· 2012-04-27
Clinical Trial Update: Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old [Phase 2]
Summary
Phase 2 trial of lucinactant for acute hypoxemic respiratory failure in children up to two years old completed; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Windtree Therapeutics | Conditions: Acute Hypoxemic Respiratory Failure | Phase 2 | Status: COMPLETED | Results posted: 2012-04-27